The doxepin vs trazodone question comes up almost every week at the pharmacy counter. Both are older medications, both are used off-label or on-label for sleep, and both are prescribed constantly because they don’t carry the same baggage as zolpidem or benzodiazepines. But "not a benzo" doesn’t automatically mean "safe for everyone."
What most patients actually want to know is simple. Which one is less likely to leave me groggy in the morning? Which one is safer if I’m older, on blood pressure meds, or worried about long-term use?
The honest answer depends on your age, your other medications, and what kind of insomnia you’re dealing with. Let’s walk through what the evidence actually says, and where the two drugs quietly differ in ways your prescriber may or may not mention.
How Each Drug Actually Works for Sleep
Doxepin is a tricyclic antidepressant, but at the very low doses used for insomnia (typically 3 mg or 6 mg), it behaves almost purely as a selective histamine H1 blocker. That’s the same receptor a Benadryl blocks, just far more targeted. The FDA approved low-dose doxepin (Silenor) specifically for sleep-maintenance insomnia in 2010.
Trazodone is a serotonin modulator. It’s FDA-approved for depression, not insomnia, though it’s one of the most commonly prescribed off-label sleep aids in the US. At bedtime doses of 25 to 100 mg, it produces sedation primarily through histamine and alpha-1 adrenergic blockade.
So in the doxepin vs trazodone comparison, you’re really comparing a narrow, low-dose antihistamine effect against a broader, messier receptor profile.
Side Effect Profiles: Where They Diverge
Both drugs cause drowsiness. That’s the point. The difference shows up in what else they do.
Low-dose doxepin’s side effect list is remarkably short. In clinical trials, headache and somnolence were the main complaints, and rates weren’t dramatically higher than placebo. Because the dose is so low, the classic tricyclic problems (dry mouth, constipation, urinary retention, blurred vision) largely don’t materialize.
Trazodone carries a longer list:
- Morning grogginess, especially at doses above 50 mg
- Orthostatic hypotension (dizziness on standing), a real concern in older adults
- Priapism, rare but a medical emergency
- QT interval prolongation at higher doses
- Dry mouth and mild anticholinergic effects
The NIH’s MedlinePlus overview of trazodone flags the orthostatic and cardiac issues specifically. That doesn’t mean trazodone is dangerous. It means the safety margin is narrower than doxepin’s, especially in patients over 65.
The Older Adult Question
This is where doxepin vs trazodone gets clinically interesting. The American Geriatrics Society Beers Criteria list most tricyclics as potentially inappropriate for older adults because of anticholinergic burden. But low-dose doxepin (6 mg or less) is specifically exempted because at that dose it doesn’t behave like a tricyclic.
Trazodone isn’t on the "avoid" list either, but it’s not exempted for a good reason. Falls from orthostatic hypotension in older adults are a real problem, and trazodone contributes to that risk. If you’re weighing sleep options for an aging parent, this distinction matters. Readers comparing this to other sleep drug tradeoffs may also want to look at the suvorexant vs zolpidem safety comparison, which covers a similar tradeoff between efficacy and next-day residual effects.
Which Type of Insomnia Are You Treating?
The other thing that separates doxepin vs trazodone is what part of the night falls apart for you.
Doxepin’s strength is sleep maintenance. It helps people who fall asleep fine but wake at 3 a.m. and can’t get back. It has a half-life of around 15 hours, which sounds long, but at 3 to 6 mg the sedation is largely gone by morning for most patients.
Trazodone works reasonably well for both sleep onset and maintenance, but the sedation is heavier and the half-life is shorter (around 7 to 10 hours). Some patients love it. Others feel underwater until 10 a.m.
If you’ve already tried melatonin or ramelteon without much success, the ramelteon vs melatonin effectiveness breakdown is worth reading before jumping to a prescription option. Not everyone needs to escalate.
Drug Interactions and Practical Cautions
Trazodone has more interaction potential. It’s metabolized primarily through CYP3A4, so drugs like ketoconazole, ritonavir, or even grapefruit juice can push blood levels higher than expected. Combining it with other serotonergic drugs (SSRIs, SNRIs, tramadol, triptans) raises serotonin syndrome risk, though the risk is low at sleep doses.
Doxepin at low doses has fewer interactions, but it still shouldn’t be combined with MAO inhibitors, and caution applies with other CNS depressants (alcohol, opioids, benzodiazepines).
Neither drug is a good idea to stop abruptly if you’ve been on it for months. Taper with your prescriber’s guidance.
For readers who want a deeper long-term safety look, we also have a related piece specifically on doxepin vs trazodone for long-term sleep use that covers dependency risk and discontinuation.
So Which Is Safer?
For most adults, particularly those over 60, low-dose doxepin has the cleaner safety profile in the doxepin vs trazodone comparison. It’s more selective, has fewer cardiovascular concerns, and doesn’t carry the orthostatic and priapism risks.
Trazodone still has a real place. It tends to work better if depression or anxiety is part of the picture, and it’s inexpensive and widely available. But "widely prescribed" isn’t the same as "safest."
If cost is a factor, compare generic doxepin and trazodone prices at edrugstore.com. Both are inexpensive generics, and the price difference usually isn’t what should drive the decision.
The Bottom Line
There’s no universal winner in doxepin vs trazodone. For a healthy 40-year-old with situational insomnia, either is reasonable. For a 72-year-old on a blood pressure medication with a history of falls, low-dose doxepin is usually the safer choice. Bring the specifics of your health history to your prescriber, ask why they’re recommending one over the other, and don’t accept "everyone gets trazodone" as an answer. Your pharmacist can also flag interactions your prescriber may not catch.
This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.
References
- FDA prescribing information for low-dose doxepin (Silenor), official approved indication and dosing for sleep-maintenance insomnia.
- MedlinePlus: Trazodone, NIH-hosted overview of trazodone side effects and warnings.
- 2023 American Geriatrics Society Beers Criteria update (PubMed), clinical guidance on medications to use with caution in older adults, including the low-dose doxepin exemption.
Dr Steven Schlosser
Dr. Schlosser graduated from Lafayette College Phi Beta Kappa and attended Georgetown Medical School. He had 4 years of medical residency training at Tufts University in Boston in both Gynecology and Internal Medicine. He has had a spotless medical career for the past 40+ years and is Board Certified. Learn More